Global Tumor Embolization Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 196216
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Tumor Embolization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Tumor Embolization size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Tumor Embolization market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Tumor Embolization market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Trans-Arterial Embolization (TAE)

Drug-Eluting Bead Chemoembolization (DEB-TACE)

Radioembolization (RE)

Others

Market segment by Application, can be divided into

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Others

Market segment by players, this report covers

Boston Scientific Corporation

Varian Medical Systems, Inc.

Nordion (Sotera Health)

Sirtex Medical

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Tumor Embolization

1.2 Classification of Tumor Embolization by Type

1.2.1 Overview: Global Tumor Embolization Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Tumor Embolization Revenue Market Share by Type in 2020

1.2.3 Trans-Arterial Embolization (TAE)

1.2.4 Drug-Eluting Bead Chemoembolization (DEB-TACE)

1.2.5 Radioembolization (RE)

1.2.6 Others

1.3 Global Tumor Embolization Market by Application

1.3.1 Overview: Global Tumor Embolization Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Specialty Clinics

1.3.5 Others

1.4 Global Tumor Embolization Market Size & Forecast

1.5 Global Tumor Embolization Market Size and Forecast by Region

1.5.1 Global Tumor Embolization Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Tumor Embolization Market Size by Region, (2016-2021)

1.5.3 North America Tumor Embolization Market Size and Prospect (2016-2026)

1.5.4 Europe Tumor Embolization Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Tumor Embolization Market Size and Prospect (2016-2026)

1.5.6 South America Tumor Embolization Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Tumor Embolization Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Tumor Embolization Market Drivers

1.6.2 Tumor Embolization Market Restraints

1.6.3 Tumor Embolization Trends Analysis

2 Company Profiles

2.1 Boston Scientific Corporation

2.1.1 Boston Scientific Corporation Details

2.1.2 Boston Scientific Corporation Major Business

2.1.3 Boston Scientific Corporation Tumor Embolization Product and Solutions

2.1.4 Boston Scientific Corporation Tumor Embolization Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Boston Scientific Corporation Recent Developments and Future Plans

2.2 Varian Medical Systems, Inc.

2.2.1 Varian Medical Systems, Inc. Details

2.2.2 Varian Medical Systems, Inc. Major Business

2.2.3 Varian Medical Systems, Inc. Tumor Embolization Product and Solutions

2.2.4 Varian Medical Systems, Inc. Tumor Embolization Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Varian Medical Systems, Inc. Recent Developments and Future Plans

2.3 Nordion (Sotera Health)

2.3.1 Nordion (Sotera Health) Details

2.3.2 Nordion (Sotera Health) Major Business

2.3.3 Nordion (Sotera Health) Tumor Embolization Product and Solutions

2.3.4 Nordion (Sotera Health) Tumor Embolization Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Nordion (Sotera Health) Recent Developments and Future Plans

2.4 Sirtex Medical

2.4.1 Sirtex Medical Details

2.4.2 Sirtex Medical Major Business

2.4.3 Sirtex Medical Tumor Embolization Product and Solutions

2.4.4 Sirtex Medical Tumor Embolization Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Sirtex Medical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Tumor Embolization Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Tumor Embolization Players Market Share

3.2.2 Top 10 Tumor Embolization Players Market Share

3.2.3 Market Competition Trend

3.3 Tumor Embolization Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Tumor Embolization Revenue and Market Share by Type (2016-2021)

4.2 Global Tumor Embolization Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Tumor Embolization Revenue Market Share by Application (2016-2021)

5.2 Tumor Embolization Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Tumor Embolization Revenue by Type (2016-2026)

6.2 North America Tumor Embolization Revenue by Application (2016-2026)

6.3 North America Tumor Embolization Market Size by Country

6.3.1 North America Tumor Embolization Revenue by Country (2016-2026)

6.3.2 United States Tumor Embolization Market Size and Forecast (2016-2026)

6.3.3 Canada Tumor Embolization Market Size and Forecast (2016-2026)

6.3.4 Mexico Tumor Embolization Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Tumor Embolization Revenue by Type (2016-2026)

7.2 Europe Tumor Embolization Revenue by Application (2016-2026)

7.3 Europe Tumor Embolization Market Size by Country

7.3.1 Europe Tumor Embolization Revenue by Country (2016-2026)

7.3.2 Germany Tumor Embolization Market Size and Forecast (2016-2026)

7.3.3 France Tumor Embolization Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Tumor Embolization Market Size and Forecast (2016-2026)

7.3.5 Russia Tumor Embolization Market Size and Forecast (2016-2026)

7.3.6 Italy Tumor Embolization Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Tumor Embolization Revenue by Type (2016-2026)

8.2 Asia-Pacific Tumor Embolization Revenue by Application (2016-2026)

8.3 Asia-Pacific Tumor Embolization Market Size by Region

8.3.1 Asia-Pacific Tumor Embolization Revenue by Region (2016-2026)

8.3.2 China Tumor Embolization Market Size and Forecast (2016-2026)

8.3.3 Japan Tumor Embolization Market Size and Forecast (2016-2026)

8.3.4 South Korea Tumor Embolization Market Size and Forecast (2016-2026)

8.3.5 India Tumor Embolization Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Tumor Embolization Market Size and Forecast (2016-2026)

8.3.7 Australia Tumor Embolization Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Tumor Embolization Revenue by Type (2016-2026)

9.2 South America Tumor Embolization Revenue by Application (2016-2026)

9.3 South America Tumor Embolization Market Size by Country

9.3.1 South America Tumor Embolization Revenue by Country (2016-2026)

9.3.2 Brazil Tumor Embolization Market Size and Forecast (2016-2026)

9.3.3 Argentina Tumor Embolization Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Tumor Embolization Revenue by Type (2016-2026)

10.2 Middle East & Africa Tumor Embolization Revenue by Application (2016-2026)

10.3 Middle East & Africa Tumor Embolization Market Size by Country

10.3.1 Middle East & Africa Tumor Embolization Revenue by Country (2016-2026)

10.3.2 Turkey Tumor Embolization Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Tumor Embolization Market Size and Forecast (2016-2026)

10.3.4 UAE Tumor Embolization Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Tumor Embolization Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Tumor Embolization Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Tumor Embolization Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Tumor Embolization Revenue (USD Million) by Region (2016-2021)

Table 5. Global Tumor Embolization Revenue Market Share by Region (2021-2026)

Table 6. Boston Scientific Corporation Corporate Information, Head Office, and Major Competitors

Table 7. Boston Scientific Corporation Major Business

Table 8. Boston Scientific Corporation Tumor Embolization Product and Solutions

Table 9. Boston Scientific Corporation Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Varian Medical Systems, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Varian Medical Systems, Inc. Major Business

Table 12. Varian Medical Systems, Inc. Tumor Embolization Product and Solutions

Table 13. Varian Medical Systems, Inc. Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Nordion (Sotera Health) Corporate Information, Head Office, and Major Competitors

Table 15. Nordion (Sotera Health) Major Business

Table 16. Nordion (Sotera Health) Tumor Embolization Product and Solutions

Table 17. Nordion (Sotera Health) Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Sirtex Medical Corporate Information, Head Office, and Major Competitors

Table 19. Sirtex Medical Major Business

Table 20. Sirtex Medical Tumor Embolization Product and Solutions

Table 21. Sirtex Medical Tumor Embolization Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Global Tumor Embolization Revenue (USD Million) by Players (2019-2021)

Table 23. Global Tumor Embolization Revenue Share by Players (2019-2021)

Table 24. Breakdown of Tumor Embolization by Company Type (Tier 1, Tier 2 and Tier 3)

Table 25. Tumor Embolization Players Head Office, Products and Services Provided

Table 26. Tumor Embolization Mergers & Acquisitions in the Past Five Years

Table 27. Tumor Embolization New Entrants and Expansion Plans

Table 28. Global Tumor Embolization Revenue (USD Million) by Type (2016-2021)

Table 29. Global Tumor Embolization Revenue Share by Type (2016-2021)

Table 30. Global Tumor Embolization Revenue Forecast by Type (2021-2026)

Table 31. Global Tumor Embolization Revenue by Application (2016-2021)

Table 32. Global Tumor Embolization Revenue Forecast by Application (2021-2026)

Table 33. North America Tumor Embolization Revenue by Type (2016-2021) & (USD Million)

Table 34. North America Tumor Embolization Revenue by Type (2021-2026) & (USD Million)

Table 35. North America Tumor Embolization Revenue by Application (2016-2021) & (USD Million)

Table 36. North America Tumor Embolization Revenue by Application (2021-2026) & (USD Million)

Table 37. North America Tumor Embolization Revenue by Country (2016-2021) & (USD Million)

Table 38. North America Tumor Embolization Revenue by Country (2021-2026) & (USD Million)

Table 39. Europe Tumor Embolization Revenue by Type (2016-2021) & (USD Million)

Table 40. Europe Tumor Embolization Revenue by Type (2021-2026) & (USD Million)

Table 41. Europe Tumor Embolization Revenue by Application (2016-2021) & (USD Million)

Table 42. Europe Tumor Embolization Revenue by Application (2021-2026) & (USD Million)

Table 43. Europe Tumor Embolization Revenue by Country (2016-2021) & (USD Million)

Table 44. Europe Tumor Embolization Revenue by Country (2021-2026) & (USD Million)

Table 45. Asia-Pacific Tumor Embolization Revenue by Type (2016-2021) & (USD Million)

Table 46. Asia-Pacific Tumor Embolization Revenue by Type (2021-2026) & (USD Million)

Table 47. Asia-Pacific Tumor Embolization Revenue by Application (2016-2021) & (USD Million)

Table 48. Asia-Pacific Tumor Embolization Revenue by Application (2021-2026) & (USD Million)

Table 49. Asia-Pacific Tumor Embolization Revenue by Region (2016-2021) & (USD Million)

Table 50. Asia-Pacific Tumor Embolization Revenue by Region (2021-2026) & (USD Million)

Table 51. South America Tumor Embolization Revenue by Type (2016-2021) & (USD Million)

Table 52. South America Tumor Embolization Revenue by Type (2021-2026) & (USD Million)

Table 53. South America Tumor Embolization Revenue by Application (2016-2021) & (USD Million)

Table 54. South America Tumor Embolization Revenue by Application (2021-2026) & (USD Million)

Table 55. South America Tumor Embolization Revenue by Country (2016-2021) & (USD Million)

Table 56. South America Tumor Embolization Revenue by Country (2021-2026) & (USD Million)

Table 57. Middle East & Africa Tumor Embolization Revenue by Type (2016-2021) & (USD Million)

Table 58. Middle East & Africa Tumor Embolization Revenue by Type (2021-2026) & (USD Million)

Table 59. Middle East & Africa Tumor Embolization Revenue by Application (2016-2021) & (USD Million)

Table 60. Middle East & Africa Tumor Embolization Revenue by Application (2021-2026) & (USD Million)

Table 61. Middle East & Africa Tumor Embolization Revenue by Country (2016-2021) & (USD Million)

Table 62. Middle East & Africa Tumor Embolization Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Tumor Embolization Picture

Figure 2. Global Tumor Embolization Revenue Market Share by Type in 2020

Figure 3. Trans-Arterial Embolization (TAE)

Figure 4. Drug-Eluting Bead Chemoembolization (DEB-TACE)

Figure 5. Radioembolization (RE)

Figure 6. Others

Figure 7. Tumor Embolization Revenue Market Share by Application in 2020

Figure 8. Hospitals Picture

Figure 9. Ambulatory Surgical Centers Picture

Figure 10. Specialty Clinics Picture

Figure 11. Others Picture

Figure 12. Global Tumor Embolization Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Tumor Embolization Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Tumor Embolization Revenue Market Share by Region (2016-2026)

Figure 15. Global Tumor Embolization Revenue Market Share by Region in 2020

Figure 16. North America Tumor Embolization Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Tumor Embolization Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Tumor Embolization Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Tumor Embolization Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Tumor Embolization Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Tumor Embolization Market Drivers

Figure 22. Tumor Embolization Market Restraints

Figure 23. Tumor Embolization Market Trends

Figure 24. Boston Scientific Corporation Recent Developments and Future Plans

Figure 25. Varian Medical Systems, Inc. Recent Developments and Future Plans

Figure 26. Nordion (Sotera Health) Recent Developments and Future Plans

Figure 27. Sirtex Medical Recent Developments and Future Plans

Figure 28. Global Tumor Embolization Revenue Share by Players in 2020

Figure 29. Tumor Embolization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 30. Global Top 3 Players Tumor Embolization Revenue Market Share in 2020

Figure 31. Global Top 10 Players Tumor Embolization Revenue Market Share in 2020

Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 33. Global Tumor Embolization Revenue Share by Type in 2020

Figure 34. Global Tumor Embolization Market Share Forecast by Type (2021-2026)

Figure 35. Global Tumor Embolization Revenue Share by Application in 2020

Figure 36. Global Tumor Embolization Market Share Forecast by Application (2021-2026)

Figure 37. North America Tumor Embolization Sales Market Share by Type (2016-2026)

Figure 38. North America Tumor Embolization Sales Market Share by Application (2016-2026)

Figure 39. North America Tumor Embolization Revenue Market Share by Country (2016-2026)

Figure 40. United States Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Tumor Embolization Sales Market Share by Type (2016-2026)

Figure 44. Europe Tumor Embolization Sales Market Share by Application (2016-2026)

Figure 45. Europe Tumor Embolization Revenue Market Share by Country (2016-2026)

Figure 46. Germany Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. France Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. United Kingdom Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Russia Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Italy Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Asia-Pacific Tumor Embolization Sales Market Share by Type (2016-2026)

Figure 52. Asia-Pacific Tumor Embolization Sales Market Share by Application (2016-2026)

Figure 53. Asia-Pacific Tumor Embolization Revenue Market Share by Region (2016-2026)

Figure 54. China Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Japan Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. South Korea Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. India Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Southeast Asia Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Australia Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. South America Tumor Embolization Sales Market Share by Type (2016-2026)

Figure 61. South America Tumor Embolization Sales Market Share by Application (2016-2026)

Figure 62. South America Tumor Embolization Revenue Market Share by Country (2016-2026)

Figure 63. Brazil Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Argentina Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Middle East and Africa Tumor Embolization Sales Market Share by Type (2016-2026)

Figure 66. Middle East and Africa Tumor Embolization Sales Market Share by Application (2016-2026)

Figure 67. Middle East and Africa Tumor Embolization Revenue Market Share by Country (2016-2026)

Figure 68. Turkey Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Saudi Arabia Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. UAE Tumor Embolization Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Methodology

Figure 72. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz